We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MBXBF market cap is 33.12M. The company's latest EPS is CAD -0.0003 and P/E is -1066.67.
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 13.41M | 10.53M | 18.59M | 19.08M | 16.52M |
| Operating Income | 1.11M | -3.6M | 4.84M | 2.61M | -2.74M |
| Net Income | 32k | -6.23M | 3.23M | 1.79M | -39k |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 19.63M | 15.6M | 28.83M | 33.15M | 35.65M |
| Total Liabilities | 9.09M | 8.98M | 10.27M | 8.21M | 11.03M |
| Total Equity | 10.54M | 6.62M | 18.56M | 24.94M | 24.62M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | 44k | 9k | 2.11M | 3.47M | -1.1M |
| Investing | -515k | -814k | -622k | -2.03M | -1.02M |
| Financing | 522k | 802k | 8.41M | 2.06M | 229k |
| Market Cap | 33.12M |
| Price to Earnings Ratio | -1066.67 |
| Price to Sales Ratio | 2.65 |
| Price to Cash Ratio | 3.77 |
| Price to Book Ratio | 1.78 |
| Dividend Yield | - |
| Shares Outstanding | 136.85M |
| Average Volume (1 week) | 2.15k |
| Average Volume (1 Month) | 8.16k |
| 52 Week Change | -13.79% |
| 52 Week High | 0.3278 |
| 52 Week Low | 0.17055 |
| Spread (Intraday) | 0.08 (29.44%) |
| Company Name | Microbix Biosystems Inc (QX) |
| Address |
265 watline avenue mississauga, ontario L4Z 1P3 |
| Website | https://www.microbix.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
